Literature DB >> 8964852

Molecular analysis of females manifesting thyroxine-binding globulin (TBG) deficiency: selective X-chromosome inactivation responsible for the difference between phenotype and genotype in TBG-deficient females.

H Okamoto1, Y Mori, Y Tani, Y Nakagomi, T Sano, K Ohyama, H Saito, Y Oiso.   

Abstract

T4-binding globulin (TBG) is the major transport protein of thyroid hormone in man. Inherited TBG abnormalities were manifested fully in hemizygous males and partially in heterozygous females and transmitted in an X-chromosome-linked fashion, compatible with its location on Xq21-22. We have previously reported that complete deficiency (CD) and partial deficiency (PD) in Japanese subjects resulted from two distinct mutations of the TBG gene, TBG-CDJ and TBG-PDJ, respectively. Recently, we encountered a female manifesting TBG-CD and herein investigated the molecular mechanisms. She was found to possess TBG-CDJ and common-type TBG (TBG-C) alleles by characterizing the TBG gene. Then, X-chromosome inactivation status was evaluated in her family members using a phosphoglycerate kinase (PGK) gene, located on Xq13. Three TBG-CDJ heterozygotes and one unaffected female, confirmed to be PGK heterozygotes for a polymorphic BstXI site, were analyzed. Only the CD female was shown to undergo selective inactivation by examining the BstXI site in amplified products after digestion with a methylation-sensitive enzyme, HpaII. Among an additional eight informative females with TBG deficiency, one heterozygous female for TBG-PDJ shared this selective inactivation pattern. Moreover, the X-chromosome with TBG-C was suggested to be inactivated selectively from the linkage of PGK and TBG alleles recognized in eight of nine family members. Selective X-chromosome inactivation was considered to be the cause of a female heterozygous for TBG-CDJ or -PDJ manifesting the same phenotype as a hemizygote.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964852     DOI: 10.1210/jcem.81.6.8964852

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  TBG deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature.

Authors:  Deborah Mannavola; Guia Vannucchi; Laura Fugazzola; Valentina Cirello; Irene Campi; Giorgio Radetti; Luca Persani; Samuel Refetoff; Paolo Beck-Peccoz
Journal:  J Mol Med (Berl)       Date:  2006-09-01       Impact factor: 4.599

Review 2.  Clinical recognition and evaluation of patients with inherited serum thyroid hormone-binding protein mutations.

Authors:  M S Mimoto; S Refetoff
Journal:  J Endocrinol Invest       Date:  2019-07-27       Impact factor: 4.256

3.  Identification of a novel mutation in thyroxine-binding globulin (TBG) gene associated with TBG-deficiency and its effect on the thyroid function.

Authors:  S Gawandi; K Jothivel; S Kulkarni
Journal:  J Endocrinol Invest       Date:  2021-11-10       Impact factor: 4.256

Review 4.  Inherited defects of thyroxine-binding proteins.

Authors:  Theodora Pappa; Alfonso Massimiliano Ferrara; Samuel Refetoff
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2015-09-30       Impact factor: 4.690

5.  A novel variant in Serpina7 gene in a family with thyroxine-binding globulin deficiency.

Authors:  Rita Domingues; Paula Font; Luís Sobrinho; Maria João Bugalho
Journal:  Endocrine       Date:  2009-05-05       Impact factor: 3.633

6.  Rare thyroid non-neoplastic diseases.

Authors:  Katarzyna Lacka; Adam Maciejewski
Journal:  Thyroid Res       Date:  2015-04-11

7.  Novel frameshift mutation causes early termination of the thyroxine-binding globulin protein and complete thyroxine-binding globulin deficiency in a Chinese family: A case report.

Authors:  Ping-Ping Dang; Wei-Wei Xiao; Zhong-Yan Shan; Yue Xi; Ran-Ran Wang; Xiao-Hui Yu; Wei-Ping Teng; Xiao-Chun Teng
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.